Heart Failure

Synonym(s):

Heart failure has been identified as a priority area for disease management in Singapore due to its high prevalence. Comprehensive heart failure disease management programmes have been shown to improve the outcome of patients with heart failure.

With the Heart Failure Programme in National Heart Centre Singapore (NHCS), we aim to improve the quality of life and survival for heart failure patients and reduce the number of re-hospitalisation through our multidisciplinary team based approach. The team comprises heart failure Cardiologists, Cardiothoracic Surgeons, Nurse Clinicians, Physiotherapists, Dieticians, and Pharmacists. Stable patients are able to return to the primary healthcare system for continual care.

Heart failure patients will be seen at our dedicated Heart Failure Clinic through a structured outpatient programme to prolong survival, improve quality of life and reduce hospital admissions. The doctor will optimise medical therapy, identifies patients who are suitable for advanced heart failure therapy and makes relevant investigations. The specialist nurse clinician will also be available on hand to provide phone consultations to patients.

For more information on heart failure symptoms, cause and risk factors, diagnosis and treatments, visit here.

Our Care Team

 

Dr Louis Teo

Deputy Head & Senior Consultant, Department of Cardiology
Director, Heart Failure Programme, NHCS

Clinical interest:

  • Heart Failure
  • Heart Transplant

View Profile

In The News

Patient Care New minimally invasive treatment for leaky heart valve at National Heart Centre Singapore The PASCAL transcatheter mitral valve repair was performed successfully for the first time in Southeast Asia at NHCS.
29 Jun 2025 | The Straits Times Read Story
Patient Care National Heart Centre Singapore Pioneers Advanced Heart Valve Repair In Southeast Asia With New Minimally Invasive Treatment NHCS has successfully performed Southeast Asia’s first PASCAL transcatheter valve repair (also known as transcatheter edge-to-edge repair), offering new hope to patients with moderate-to-severe and severe mitral regurgitation who were previously considered too high-risk for conventional surgical repair or valve replacement.
23 Jun 2025 Read Story